Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Pathogenesis of Terson Syndrome and the Role of CSF Tau / Amyloid-ß 40 and 42 in Patients With Aneurysmatic Subarachnoid Hemorrhage

NCT02129010 is registered in ClinicalTrials.gov with Holger Joswig as lead sponsor.

NCT NCT02129010
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02129010 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Pathogenesis of Terson Syndrome and the Role of CSF Tau / Amyloid-ß 40 and 42 in Patients With Aneurysmatic Subarachnoid Hemorrhage
Lead sponsor
Holger Joswig
Phase
Observational
Overall status
Completed
Start date
April 30, 2013
Completion date
February 29, 2016
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

csf-proteines, subarachnoid hemorrhage, terson syndrome